INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 151 filers reported holding INSMED INC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,664 | +19.7% | 343,110 | 0.0% | 0.12% | +26.9% |
| Q2 2023 | $7,240 | +23.8% | 343,110 | 0.0% | 0.09% | +16.2% |
| Q1 2023 | $5,850 | -14.7% | 343,110 | 0.0% | 0.08% | -12.1% |
| Q4 2022 | $6,855 | -99.9% | 343,110 | 0.0% | 0.09% | -10.8% |
| Q3 2022 | $7,391,000 | +9.2% | 343,110 | 0.0% | 0.10% | +20.0% |
| Q2 2022 | $6,766,000 | -16.1% | 343,110 | 0.0% | 0.08% | -3.4% |
| Q1 2022 | $8,063,000 | -13.7% | 343,110 | 0.0% | 0.09% | 0.0% |
| Q4 2021 | $9,346,000 | -1.1% | 343,110 | 0.0% | 0.09% | -9.3% |
| Q3 2021 | $9,449,000 | -3.2% | 343,110 | 0.0% | 0.10% | -4.0% |
| Q2 2021 | $9,765,000 | -16.4% | 343,110 | 0.0% | 0.10% | -11.4% |
| Q1 2021 | $11,686,000 | -8.4% | 343,110 | -10.4% | 0.11% | -10.9% |
| Q4 2020 | $12,754,000 | -10.4% | 383,110 | -13.5% | 0.13% | -20.0% |
| Q3 2020 | $14,242,000 | +16.7% | 443,110 | 0.0% | 0.16% | +12.7% |
| Q2 2020 | $12,203,000 | +71.8% | 443,110 | 0.0% | 0.14% | +43.4% |
| Q1 2020 | $7,103,000 | -32.9% | 443,110 | 0.0% | 0.10% | -21.4% |
| Q4 2019 | $10,581,000 | +35.4% | 443,110 | 0.0% | 0.13% | +27.3% |
| Q3 2019 | $7,816,000 | -22.3% | 443,110 | +12.7% | 0.10% | -20.8% |
| Q2 2019 | $10,064,000 | +206.1% | 393,110 | +247.5% | 0.12% | +197.6% |
| Q1 2019 | $3,288,000 | +121.6% | 113,110 | 0.0% | 0.04% | +100.0% |
| Q4 2018 | $1,484,000 | -69.5% | 113,110 | -53.0% | 0.02% | -66.1% |
| Q3 2018 | $4,866,000 | -49.9% | 240,642 | -41.4% | 0.06% | -54.1% |
| Q2 2018 | $9,719,000 | +15.8% | 410,954 | +10.3% | 0.14% | +4.7% |
| Q1 2018 | $8,392,000 | -31.3% | 372,662 | -4.9% | 0.13% | -27.1% |
| Q4 2017 | $12,223,000 | -12.5% | 392,007 | -12.4% | 0.18% | -10.6% |
| Q3 2017 | $13,964,000 | +475.1% | 447,429 | +216.3% | 0.20% | +435.1% |
| Q2 2017 | $2,428,000 | +13.2% | 141,471 | +15.5% | 0.04% | +2.8% |
| Q1 2017 | $2,144,000 | – | 122,450 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |